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Conclusion: For the small lesions with a volume smaller than 
4 cm³ the Agility shows a steeper gradient in the two 
surrounding rings than the MLCi1. Therefore we recommend 
the use of the Agility for treating the smaller lesions.  
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Purpose or Objective: To obtain a planning technique for 
SBRT treatment of multiple lung tumors, which is suitable for 
all relative positions of the tumors. 
 
Material and Methods: For 10 patients with two tumors, 
treated with 3 x 18Gy, VMAT plans were generated in 
Pinnacle, using various approaches: simultaneous versus 
sequential optimization, with or without the dose distribution 
of one tumor as background for optimization of the other 
tumor. The quality of the treatment plans was judged on 
coverage (PTV V100% >95%), conformity (V100%/PTV volume), 
inhomogeneity (PTV D0<165%) and dose constraints on OARs.  
 
Results: Simple addition of beams for two independently 
planned tumors does not yield optimal results since the 
mutual low dose contributions cannot be taken into account 
properly. Simultaneous optimization on both targets results 
in pairs of open leafs in-between the lesions (Fig 1). We 
therefore concluded that the strategy that yields the most 
conformal plans is the subsequent planning of the tumors 
using a dual-arc for both, where the dose distribution 
resulting from the planning of the first target is used as a 
background dose while optimizing the beams for the second 
target. During optimization of the first tumor, no limit is 
applied for the dose to the second PTV, since this can be 
compensated for in the optimization procedure for this PTV. 
After optimization of the second PTV, the number of monitor 
units in each beam pair might be adjusted slightly to conform 
to the required target coverage. This strategy works for two 
or more isocenters as well as for one mutual isocenter. For 
three or more tumors, iterating the above method yields 
good results 
 
 
Conclusion: We developed a generic planning strategy to 
obtain high quality lung SBRT-treatment plans for patients 
with multiple lung tumors. The strategy uses a dual-arc VMAT 
for each tumor, while taking the dose distribution covering 
the first target is used as background during dose 
optimization for the second target. This method is clinically 
in use since March 2015, since then 15 patients have been 
treated using this method. 
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Purpose or Objective: Two centers compared 
VMAT/RapidArc (RA) and Tomotherapy (TOMO). for the 
irradiation of breast and regional lymph nodes. 
 
Material and Methods: Five left and five right breasts plus 
regional nodes have been contoured by two dedicated 
radiation oncologists. Two senior physicists checked the 
treatment plans studied by dedicated dosimetrists. The 
Anatom-e tool was tested for improving definition and 
avoiding interpersonal variability in the contouring. 
Prescription, according to ICRU, was 50 Gy in 25 daily 
fractions. We considered both lungs, the heart, the left 
anterior descending coronary artery (LAD), the controlateral 
breast and the thyroid as Organa t Risk (OaR). The dose 
constraints were: PTV V95=95%, ipsilateral lung V20 ≤20%, 
heart mean dose < 10Gy, heart max dose <35Gy, LAD max 
dose ≤20Gy, thyroid max dose < 45 Gy and contralateral 
breast max dose≤5 Gy. We have studied the treatments in 
free breathing modality, perfectly aware of the higher dose 
received by heart and LAD in comparison to the respiratory- 
gated modality, routinely used in the RA center. 
 
Results: We summarized the results of this comparison in 
Table 1  
Table 1. Left and right breast plus lymphnodes. 
 
 
 
Conclusion: Both techniques allow a good coverage and dose 
uniformity for the PTV, with proper sparing of the OaR. TOMO 
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allows greater hearth and LAD sparing in left cases, when 
compared to RA with no gating. Of note beam-on time, in RA 
modality, is highly decreased. 
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Purpose or Objective: Many strategies have been explored in 
attempt to reduce the cardiac dose and the lung dose during 
breast irradiation. Here we investigated the efficacy of user 
optimised collimator rotation and jaws setting, in static 
gantry IMRT with simultaneous integrated boost (SIB), on 
hearth and lung dose sparing. 
 
Material and Methods: From September 2010 to March 2014, 
69 patients were treated for left breast (PTV-breast) cancer 
with SIB at surgical bed (PTV-boost) in 25 fractions: the 
prescribed doses (Dp) were 50 Gy and 60 Gy, respectively. All 
plans were generated with Varian EclipseTM v.10.0.28 TPS, 
using 5-7 IMRT sliding-window fields equally spaced along a 
190° arc, with 6MV photon beams and a Varian 
Millenium120TM multileaf collimator. Dose computation were 
performed by AAA algorithm, with a 2.5 mm grid size. The 
first 41 patients were planned by fixing a null collimator 
rotation, and by leaving the optimizer Varian DVOTM 
v.10.0.28 free to search for the optimal setting of the jaws 
(IMRT-A). In the next 28 patients the arrangement of the two 
outermost tangential fields were set to maximally spare the 
heart and the left lung. In details, the collimator was rotated 
so as to align the medial jaw with the projection of the chest 
wall (IMRT-B). Further, for the most lateral field the jaws 
were collimated to the lateral and central portions only of 
the PTV-breast. The remaining 3-5 fields covered entire 
target according the BEV projection of the target. By 
selecting the Fixed Jaws Parameter of the two outermost 
fields into DVO the same jaws aperture defined in BEV were 
assured during optimization process. Plans aimed to cover at 
least 95% of the PTVs volume with a dose ³ 95% of the Dp 
(V95% ³95%), with V107%<2%, for PTV-boost. Hearth volume 
receiving more then 20 Gy (V20)<10%. Left lung V20<20%. 
Right breast mean dose (Dmean)<2Gy and right lung 
Dmean<3Gy. By hypothesis testing, several dose-volume 
metrics were then compared across the two groups of plans. 
 
Results: As detailed in Table 1, although a slightly reduced 
V95% to PTV-breast was associated with IMRT(B), both 
techniques assured to any patient the required target dose 
coverage. In terms of dose sparing to the OARs, IMRT(B) was 
associated with a 25.6% reduction in the median of Dmean to 
the heart, while the heart V5, V10 and V20 were respectively 
reduced by 21.1%, 49.8%, and 52.1% (all p<0.002). Further, 
the median of Dmean to the left lung decreased by 21.2%, 
while V5, V10 and V20 to this organ decreased by 5.4%, 36.8% 
and 28.6%, respectively (all p<0.003). No significant 
differences resulted for Dmean to the right breast and lung. 
 
 
 
Conclusion: Similar PTVs coverage were obtained with both 
IMRT techniques, the selection from an experienced user of 
collimator rotation and fixed jaws settings for the two 
outermost tangential fields in a 5-7 fields sliding-window 
IMRT (IMRT-B) resulted in a significant reduction of the dose 
to the heart and the ipsilateral lung. 
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Purpose or Objective: It was reported in literature that 
increasing the number of arcs from 1 to 4-8 improves the 
quality of head and neck (HN) VMAT plans with 
simultaneously integrated boost (SIB). Aim of this work is to 
optimize the performance of triple-arc VMAT (TAV) against 
conventional IMRT for three dose level irradiation of 
advanced HN cancer. 
 
Material and Methods: A retrospective planning study was 
conducted on a sample of 10 patients with HN cancer 
previously treated with IMRT. PTVs were delineated for 3 
different dose levels (70, 63 and 56 Gy in 35 fractions) 
delivered by a SIB technique. All plans were generated with 6 
MV x-rays for a Varian Clinac iX linac. Optimization and 
calculations were done in the Varian Eclipse system (v. 
10.0.28). IMRT plans included 7 equally placed beams using 
sliding window technique. Three TAV plans were generated 
for each patient: triple full-arc plan, 3F (collimator angles 
(CA): 0°, 20°, 340°); double full + partial arc plan, 2FP0 (CA: 
20°, 340°; 0° for partial arc); double full + partial arc plan, 
2FP90 (CA: 20°, 340°; 90° for partial arc). Dose 
normalization was set as D(95%)=70 Gy for the primary 
tumour and involved nodes (PTV70), while planning 
objectives were D(95%)≥ 95% of prescription dose for the 
high- and low-risk target volumes (PTV63 and PTV 56). OARs 
taken into account into optimization included the brainstem, 
spinal cord, parotids, oral mucosa, larynx, mandible, 
vertebrae, thyroid. The healthy tissue was defined as the 
body volume excluding the PTVs. Planning objectives are 
shown in Table 1. The parameters used for plan comparison 
include PTV coverage, dose homogeneity (HI) and conformity 
(CI), OAR sparing, healthy tissue integral dose (HTID) and 
number of MUs. 
 
Results: Table 1 shows the results of PTV coverage, 
homogeneity, conformity, and doses to OARs for the 4 
planning techniques. Similar coverage of all PTV’s is obtained 
in all the techniques. TAV plans show better homogeneity 
and conformity in PTV70 compared to IMRT, though the 
difference is significant only for HI of the 2FP90 technique. 
For spinal cord and vertebrae the 2FP90 plans show 
significant reductions of maximum dose. No significant 
